Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults
Open Access
- 25 September 2024
- journal article
- research article
- Published by Elsevier in Vaccine: X
- Vol. 20, 100564
Abstract
No abstract availableKeywords
Funding Information
- Universitetet i Bergen
- Helse Vest (F-12167)
- Helse Vest (F-12621)
- Helse Vest (F-11628)
- European Commission (IMI 2 101007799)
- European Commission (H2020 101037867)
- European Commission (H2020 874866)
- European Commission (IMI 115672)
- Norges Forskningsråd (284930)
- Trond Mohn stiftelse (TMS2020TMT05)
- Haukeland Universitetssjukehus
- Helse- og Omsorgsdepartementet
This publication has 60 references indexed in Scilit:
- Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humansImmunity, 2024
- LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulationImmunity, 2024
- Effect of vaccine dosing intervals on Omicron surrogate neutralization after three doses of BNT162b2Heliyon, 2023
- Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25high regulatory and memory T cellsCellular Immunology, 2023
- The memory B cell response to influenza vaccination is impaired in older personsCell Reports, 2022
- Comparison between enzyme‐linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS‐CoV‐2 after symptomatic COVID‐19Immunity, Inflammation and Disease, 2022
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variantCell, 2022
- Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lungCell, 2021
- Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironmentCell Reports, 2021
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020